Number of orphan designations accepted in the U.S. 2003-2018
Annual number of accepted orphan designations in the United States from 2003 to 2018
This statistic displays the number of accepted orphan designations per year in the United States from 2003 to 2018. In 2008, there were 164 orphan designations accepted in the country. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Annual number of accepted orphan designations in the United States from 2003 to 2018
Loading statistic...
| Number of orphan designations | |
|---|---|
| 2018 | 335 |
| 2017 | 461 |
| 2016 | 317 |
| 2015 | 349 |
| 2014 | 288 |
| 2013 | 261 |
| 2012 | 192 |
| 2011 | 200 |
| 2010 | 193 |
| 2009 | 166 |
| 2008 | 164 |
| 2007 | 120 |
| 2006 | 142 |
| 2005 | 124 |
| 2004 | 132 |
| 2003 | 94 |
Source
More information
Statistics on "Orphan drugs"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Number of cumulative orphan designations accepted in the U.S. 2003-2018
- Leading orphan designations in the EU by indication 2015
- Median length of orphan and non-orphan drugs in phase III trial 2015
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Top new orphan molecular entities by U.S. sales in 2019
- Leading orphan drugs based on R&D phase III cost 2015
- Median length of time for orphan and non-orphan drugs for FDA approval 2015
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Orphan vs. non-orphan pipeline sales forecast worldwide 2019-2024
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Pricing of orphan drugs across three countries on annual basis 2016
- Utilization of orphan drugs in the U.S. by usage type 2014
- Orphan drug spending growth characteristics in the U.S. 2012-2017
- FDA approved orphan drugs with non-orphan indications 1983-2018
- Heparin global market distribution 2016, by region
- Health and social care employees in Austria 2000-2016
- Total U.S. OTC hyaluronic acid market size by application 2014-2024
Statistics on "Orphan drugs"
Related topics
About Statista
